7 Laggards That Are Bargains In 2017: SHLD, GNC, CLDX, HBI, ALXN

Sears (SHLD), Noodles (NDLS), Celldex Therapeutics (CLDX), Hanesbrands (HBI), CPI Card (PMTS), GNC, & Alexion (ALXN) are laggards with turnaround potential.

Posted in Members, Portfolio Strategy, Timely Analysis | Tagged , , , , , , , , , , , , , | 1 Comment

Celldex Therapeutics, Inc: Why CLDX Stock Could Shock Investors In 2017

Celldex stock loss is the result of Rintega, but Glenbatumaumab, or CDX-011 is what pushed CLDX stock higher before. It could happen again.

Posted in Healthcare & Biotech | Tagged , | Leave a comment

RAD Stock: Walgreens-Rite Aid Merger Shines Doubt

RAD stock performance does not reflect the near-term Rite Aid buyout, and while the Walgreens-Rite Aid merger looks like a sure thing, investors need to remember CLDX stock when considering “sure things” in the market.

Posted in Healthcare & Biotech, Mergers & Acquisitions | Tagged , , , , , | Leave a comment